Swiss Pharma Company – IDEOGEN takes over Special Access Program for BELEODAQ® (belinostat)
January 22, 2022 — 04:24 CST
This Data Is Locked!
This area is available only to Subscribers.
HURDEN, Switzerland, Jan. 22, 2022 /PRNewswire/ -- IDEOGEN GROUP, Managed Access division, takes over Special Access Program for BELEODAQ® (belinostat) in Europe, Middle East, North Afri...... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
